Abbott Laboratories (ABT) EPS (Basic) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.12% |
| Dec 31, 2025 | -3.71% |
| Sep 30, 2025 | 6.38% |
| Jun 30, 2025 | 27.73% |
| Mar 31, 2025 | 19.64% |
| Dec 31, 2024 | 55.01% |
| Sep 30, 2024 | 11.72% |
| Jun 30, 2024 | 5.36% |
| Mar 31, 2024 | 13.00% |
| Dec 31, 2023 | 19.98% |
| Sep 30, 2023 | 20.71% |
| Jun 30, 2023 | 13.47% |
| Mar 31, 2023 | 25.59% |
| Dec 31, 2022 | 26.42% |
| Sep 30, 2022 | 19.25% |
| Jun 30, 2022 | 50.29% |
| Mar 31, 2022 | 44.37% |
| Dec 31, 2021 | 17.04% |
| Sep 30, 2021 | 47.22% |
| Jun 30, 2021 | 10.32% |
| Mar 31, 2021 | 90.37% |
| Dec 31, 2020 | 21.54% |
| Sep 30, 2020 | 11.52% |
| Jun 30, 2020 | -10.42% |
| Mar 31, 2020 | -2.40% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 13.24% |
| Jun 30, 2019 | 15.28% |
| Mar 31, 2019 | 9.63% |
| Dec 31, 2018 | 3.60% |
| Sep 30, 2018 | -12.39% |
| Jun 30, 2018 | 10.93% |
| Mar 31, 2018 | -3.71% |
| Dec 31, 2017 | -7.78% |
| Sep 30, 2017 | 10.12% |
| Jun 30, 2017 | -10.42% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | -13.11% |
| Sep 30, 2016 | -26.69% |
| Jun 30, 2016 | -19.86% |
| Mar 31, 2016 | -41.01% |
| Dec 31, 2015 | -13.13% |
| Sep 30, 2015 | -7.16% |
| Jun 30, 2015 | -8.93% |
| Mar 31, 2015 | -11.65% |
| Dec 31, 2014 | -9.83% |
| Sep 30, 2014 | -21.13% |
| Jun 30, 2014 | -19.53% |